Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)
MXN 26.54
(-0.64%)
MXN 26.54
(-0.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.24 Billion | 2.05 Billion | 1.46 Billion | 1.71 Billion | 1 Billion | 1.56 Billion |
| Net Income | 1.08 Billion | 1.38 Billion | 1.3 Billion | 1.47 Billion | 764.46 Million | 1.1 Billion |
| Depreciation & Amortization | 227.3 Million | 227.12 Million | 170.26 Million | 158.99 Million | 142.19 Million | 81.16 Million |
| Deferred income taxes | - | - | - | - | - | 75.11 Million |
| Stock-based compensation | - | - | - | - | - | 5.23 Million |
| Change in working capital | 458.65 Million | -273.6 Million | -811.39 Million | -434.17 Million | -932.56 Million | -280.46 Million |
| Other non-cash items | 737.81 Million | 712.07 Million | 801.61 Million | 519.32 Million | 1.03 Billion | 571.96 Million |
| Investing Cash Flow | -302.21 Million | -282.29 Million | -765.61 Million | -663.65 Million | -844.64 Million | -1.36 Billion |
| Investments in PPE | -88.89 Million | -19.47 Million | -206.57 Million | -7.77 Million | -876.6 Million | -1.51 Billion |
| Acquisitions | - | - | - | - | - | 107.34 Million |
| Investment purchases | -144.89 Million | -205.92 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -157.31 Million | -262.82 Million | -559.03 Million | -655.87 Million | 31.96 Million | 38.03 Million |
| Financing Cash Flow | -1.67 Billion | -1.36 Billion | -1.46 Billion | 189.84 Million | -622.23 Million | 472.9 Million |
| Debt repayment | -89.06 Million | -3.82 Billion | -2.57 Billion | -4.39 Billion | -3.43 Billion | -3.76 Billion |
| Dividends payments | -580.7 Million | -777.66 Million | -391.75 Million | - | - | - |
| Common Stock Repurchased | -1.9 Billion | -994.92 Million | -155.8 Million | -15.44 Million | -90.9 Million | -133.93 Million |
| Common Stock Issuance | 1.74 Billion | 471.14 Million | 76.9 Million | 283.33 Million | 6.75 Million | - |
| Other Financing Activities | -844.78 Million | 3.76 Billion | 1.57 Billion | 4.32 Billion | 2.89 Billion | 4.37 Billion |
| Accounts receivables | 66.34 Million | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -164.18 Million | -434.59 Million | -227.6 Million | -227.55 Million | -359.89 Million | -411.87 Million |
| Other working capital | 556.49 Million | 160.98 Million | -583.79 Million | -206.61 Million | -572.66 Million | 131.4 Million |
| Cash at beginning of period | 1.29 Billion | 1.26 Billion | 2.1 Billion | 922.94 Million | 1.41 Billion | 1.09 Billion |
| Cash at end of period | 1.48 Billion | 1.5 Billion | 1.26 Billion | 2.1 Billion | 922.94 Million | 1.41 Billion |
| Capital Expenditure | -88.89 Million | -19.47 Million | -206.57 Million | -7.77 Million | -876.6 Million | -1.51 Billion |
| Effect of forex changes on cash | -77.58 Million | -171.06 Million | -72.53 Million | -59.79 Million | -31.75 Million | -346.58 Million |
| Net cash flow / Change in cash | 190.39 Million | 239.03 Million | -839.03 Million | 1.18 Billion | -491.7 Million | 321.9 Million |
| Free Cash Flow | 2.15 Billion | 2.03 Billion | 1.26 Billion | 1.7 Billion | 130.33 Million | 50.19 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 660.06 Million | 631.64 Million | 372.1 Million | -61.15 Million | 1.08 Billion | 370.67 Million |
| Depreciation & Amortization | 88.52 Million | 59.84 Million | 90.02 Million | 37.09 Million | 227.3 Million | 60.35 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 490.29 Million | -677.73 Million | -810.95 Million | 524.98 Million | 458.65 Million | 161.86 Million |
| Other non-cash items | 224.53 Million | 245.03 Million | 268.77 Million | 314.98 Million | 737.81 Million | 68.89 Million |
| Investing Cash Flow | -595.33 Million | -55.29 Million | -35.78 Million | -316.59 Million | -302.21 Million | 41.42 Million |
| Investments in PPE | -41.17 Million | -16.09 Million | -45.96 Million | - | -88.89 Million | -50.49 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -144.89 Million | - |
| Sales/Maturities of investments | 1.96 Million | 7.08 Million | - | - | - | - |
| Other Investing Activities | -556.13 Million | -58.66 Million | -25.56 Million | - | - | 91.91 Million |
| Financing Cash Flow | -313.31 Million | -300.78 Million | -357.89 Million | -678.51 Million | -1.67 Billion | -262.02 Million |
| Debt repayment | -131.99 Million | -77.33 Million | -74.84 Million | -179.76 Million | -89.06 Million | -812.81 Million |
| Dividends payments | -195.67 Million | -208.18 Million | -191.81 Million | - | -580.7 Million | -193.67 Million |
| Common Stock Repurchased | -671 Thousand | - | -40.88 Million | -1.11 Billion | -1.9 Billion | -350.29 Million |
| Common Stock Issuance | - | 68.45 Million | - | - | 1.74 Billion | 376.89 Million |
| Other Financing Activities | -248.97 Million | -238.38 Million | - | - | - | 717.86 Million |
| Accounts receivables | 251.44 Million | -68.42 Million | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -67.19 Million | -60.02 Million | -154.67 Million | 194.4 Million | -164.18 Million | -201.48 Million |
| Other working capital | 306.05 Million | -549.27 Million | - | - | - | 363.35 Million |
| Cash at beginning of period | 1.23 Billion | 1.14 Billion | 1.67 Billion | 1.74 Billion | 1.29 Billion | 1.36 Billion |
| Cash at end of period | 1.82 Billion | 1.21 Billion | 1.11 Billion | 1.48 Billion | 1.48 Billion | 1.74 Billion |
| Capital Expenditure | -41.17 Million | -16.09 Million | -45.96 Million | - | -88.89 Million | -50.49 Million |
| Effect of forex changes on cash | 41.01 Million | 35.23 Million | -9.31 Million | 105.93 Million | -77.58 Million | -46.84 Million |
| Net cash flow / Change in cash | 595.77 Million | 74.93 Million | -552.65 Million | -252.36 Million | 190.39 Million | 371.09 Million |
| Free Cash Flow | 1.42 Billion | 395.98 Million | -172.41 Million | 819.48 Million | 2.15 Billion | 611.29 Million |
JGSMY
PLSV
LNR
BANEP
000922
I93